Sanbo Brain Science announced that TBP 3Doctors Limited, a shareholder holding 5% or more of its shares, had previously planned to reduce its holdings by no more than 4,059,800 shares from June 29, 2026 to September 28, 2026, accounting for 2.00% of the total share capital after excluding the number of shares in the company's special account to be repurchased. As of the disclosure date of the announcement, the holdings reduction plan period ended, and the actual holdings were reduced by 3.488 million shares, accounting for 1.69% of the company's total share capital; after the change, 267.17,400 shares were held, accounting for 12.97% of the company's total share capital. This change in equity hit an integer multiple of 1% and would not lead to a change in the company's control.

Sanbo Brain Science announced that TBP 3Doctors Limited, a shareholder holding 5% or more of its shares, had previously planned to reduce its holdings by no more than 4,059,800 shares from June 29, 2026 to September 28, 2026, accounting for 2.00% of the total share capital after excluding the number of shares in the company's special account to be repurchased. As of the disclosure date of the announcement, the holdings reduction plan period ended, and the actual holdings were reduced by 3.488 million shares, accounting for 1.69% of the company's total share capital; after the change, 267.17,400 shares were held, accounting for 12.97% of the company's total share capital. This change in equity hit an integer multiple of 1% and would not lead to a change in the company's control.